Open Access Article
This Open Access Article is licensed under a
Creative Commons Attribution 3.0 Unported Licence

Elucidating decay pathways of bispidine–iron(IV)–tosylimido complexes: insights gained from decay products

Thomas Josephy a, Fridolin Röhs c, Thorsten Glaser c, Peter Comba ad and Katharina Bleher *ab
aUniversität Heidelberg, Anorganisch-Chemisches Institut, INF 270, D-69120 Heidelberg, Germany. E-mail: Katharina.bleher@kit.edu
bInstitute of Functional Interfaces, Karlsruhe Institute of Technology, Hermann-von-Helmholtz-Platz 1, 76344, Eggenstein-Leopoldshafen, Germany
cUniversität Bielefeld, Lehrstuhl für Anorganische Chemie I, Fakultät für Chemie, Universitätsstr. 25, D-33615 Bielefeld, Germany
dUniversität Heidelberg, Interdisziplinäres Zentrum für Wissenschaftliches Rechnen (IWR), Germany

Received 28th August 2025 , Accepted 9th October 2025

First published on 20th October 2025


Abstract

This study investigates the degradation pathways of three iron(IV)–tosylimido complexes coordinated by tetra- and pentadentate bispidine ligands, a class of rigid nitrogen-donor frameworks based on the 3,7-diazabicyclo[3.3.1]nonane scaffold. Using a combination of spectroscopic (UV-vis-NIR, EPR, Mössbauer) and spectrometric techniques (HR ESI-MS/MS) it was revealed that two of the complexes, derived from a tetradentate bispidine ligand and a pentadentate bispidine ligand, follow a common degradation route. This involves initial reduction to a high-spin iron(III) species, followed by ligand demethylation at a nitrogen donor. The demethylation step is confirmed by the elimination of a CH2NTs (tosylaminomethyl) fragment, as detected by tandem mass spectrometry. This transformation is analogous to formaldehyde loss observed in the degradation of related bispidine-iron(IV)–oxido complexes. In contrast, an isomeric iron(IV)–tosylimido complex bearing a structurally similar pentadentate bispidine ligand follows a distinct pathway, forming a low-spin iron(III)–amido complex of the type [(L)Fe–NHTs]2+. Mössbauer parameters support this assignment and align with previously reported low-spin iron-amido species. We attribute the difference in reactivity to the orientation of the tosylimido group within the coordination sphere: axial in the isomeric pentadentate ligand, but equatorial in the other two. This spatial change influences both the electronic structure and the accessibility of the tosylimido moiety. Although direct observation of the transient iron(IV)–tosylimido intermediate remains elusive in the tetradentate system due to its high reactivity, analysis of its degradation products provides indirect but compelling evidence for its formation. All complexes mediate NTs transfer to styrene, supporting the presence of tosylimido intermediates and offering a platform for rational catalyst design through ligand and counter ion tuning.


Introduction

High-valent heme and nonheme metal–oxygen and metal–nitrogen complexes are powerful oxidants, playing pivotal roles in enzymatic transformations. These complexes have been extensively studied for their ability to transfer oxygen and nitrogen containing groups as fundamental reactions in both natural and synthetic chemistry.1–6 Among these, nonheme iron–oxido species have been particularly well characterized, with diverse examples spanning multiple oxidation and spin states, as well as other catalytically active oxygen containing species such as superoxido and peroxide complexes.7–12 These studies have laid a strong foundation for understanding structure–reactivity relationships in iron–oxido chemistry through kinetic, spectroscopic, and quantum-chemical approaches. Since the early 2000s iron–imido complexes have gained increasing interest; however, detailed insight into their structural, spectroscopic, and mechanistic properties remains limited.13–18

Iron–imido species, in particular iron(IV)–tosylimido complexes, hold great potential for nitrene transfer chemistry, including aziridination and amination of hydrocarbons, offering promising routes for C–N bond formation.19–21 Such transformations are critical in the synthesis of nitrogen-containing molecules with applications ranging from pharmaceuticals22,23 to advanced materials.24 Studies involving among others copper,25–31 manganese,32,33 and iron complexes34,35 have demonstrated the utility of metal–imido systems for nitrene transfer. Spectroscopically characterized examples have been widely reported and comparisons of reactivity with the well-studied iron–oxido species suggest intriguing differences.35–39 Typically, iron–tosylimido complexes are orders of magnitude slower in group transfer reactions and exhibit slower rates for hydrogen atom transfer (HAT) compared to their oxido counterparts. However, iron(IV)–tosylimido complexes can show enhanced reactivity in certain sulfoxidation reactions, attributed to differences in electron transfer properties and sterics.20,40

In general, the observed reactivity is sufficient to trigger various decomposition processes, similar to the formation of iron(III)–hydroxido compounds or N-centered demethylation of the used ligand as seen in oxido analogs.41–43 It has been shown that tosylimido groups can form [Fe–NHTs] species via proton coupled electron transfer (see Scheme 1, pathway B).34 These species are likewise capable of transferring the amine group, thereby aminating the respective substrate instead of forming a nitrene or aziridine.44,45 Furthermore, the tosylimido group, as seen in many cases of oxido chemistry, can attack its own ligand, triggering an intramolecular rearrangement (Scheme 1, pathway A).14 Due to this, acquiring iron(IV)–tosylimido spectra without any impurities is often challenging, as many of these decay processes occur immediately upon the oxidation of the precursor.


image file: d5dt02063h-s1.tif
Scheme 1 Observed decomposition pathways of iron(IV)–tosylimido species, exemplarily shown on a complex with a tetradentate bispidine ligand.

Recently, iron(IV)–tosylimido complexes supported by the two isomeric pentadentate bispidine ligands L2 and L3 (see Fig. 1 for all used ligands in this manuscript and their complex structures) have been reported and characterized.40 In contrast, no spectroscopic data are available for the tosylimido species of the tetradentate ligand L1. The absence of experimental evidence for the L1-bound tosylimido complex is attributed to an enhanced decay rate of the tosylimido intermediate, preventing its direct detection. On the basis of the exceptionally high reactivity of the iron(IV)–oxido complex with L1, it was hypothesized that the L1-supported tosylimido species might likewise exhibit increased reactivity compared to other tosylimido species.41 To probe this, we conducted experiments aimed at identifying the elusive iron(IV)–tosylimido intermediate and elucidating its decay pathways. Our strategy involved a comparative study of the L1-based system alongside the previously characterized L2 and L3 complexes to establish whether the same decomposition products are observed across all three ligands. Such a correlation would support the formation of a common reactive intermediate. Herein, we report our findings based on HR ESI-MS, UV-vis-NIR, Mössbauer, and EPR spectroscopy, complemented by catalytic aziridination reactions using styrene as substrate.


image file: d5dt02063h-f1.tif
Fig. 1 Illustration of the ligands and complexes mentioned in the manuscript. For the complexes, X and Y are either a solvent molecule, anion or the tosylimido group.

Results and discussion

Characterization of the decay species

UV-vis-NIR spectroscopy. The combination of various spectroscopic methods is often required to fully characterize a reactive species or its degradation products. Accordingly, a combination of methods was employed in this study to capture the nature of the observed degradation products formed from bispidine-iron(IV)–tosylimido species. A commonly used method to observe the formation of reactive species of transition metal complexes is UV-vis-NIR spectroscopy. When a solution of the complexes of the pentadentate bispidines [(L2)FeII(MeCN)](OTf)2 and [(L3)FeII(MeCN)](OTf)2 (0.5 mM, dry MeCN, Ar) are treated with 3 equivalents of the oxidizing agent PhINTs ((N-(p-toluenesulfonyl)imino)phenyliodinane), the formation of the tosylimido species can be observed by monitoring the corresponding absorption bands, see Fig. 2a and c. The tosylimido species for [(L2/3)FeIV[double bond, length as m-dash]NTs]2+ exhibit the same dd transitions at 735 nm or 730 nm, respectively, as known for their oxido analogues. The maxima are not shifted as the involved orbitals of this transition are not directly influenced by the coordinating oxido or tosylimido group.40,46 Additionally, the tosylimido species [(L3)FeIV[double bond, length as m-dash]NTs]2+ shows an intense charge-transfer band at 475 nm, as also reported for the tosylimido complex [(L6)FeIV[double bond, length as m-dash]NTs]2+.35 When the solutions are left to stand, the corresponding tosylimido bands of both complexes decrease as the tosylimido species transform into decay products, which do not correspond to the iron(II) precursor but to iron(III) species, with bands at 530 nm or 500 nm, respectively. The time for the complete decay of the corresponding tosylimido bands differs significantly, ranging from a few minutes to several hours.
image file: d5dt02063h-f2.tif
Fig. 2 (a) Time-dependent progression of the oxidation of [(L2)FeII(MeCN)]2+ to the tosylimido species and its subsequent decay; the insert shows the isosbestic point observed during the decay of the tosylimido species. (b) Time-dependent progression of the absorptions at 780 nm (for the iron(IV)–tosylimido species; maximum at 735 nm) and 530 nm (decay product) for [(L2)FeIV[double bond, length as m-dash]NTs]2+. (c) Time-dependent progression of the oxidation of [(L3)FeII(MeCN)]2+ to the tosylimido species and its subsequent decay. (d) Overview of all resulting iron(III) degradation products after oxidation with PhINTs. Resulting structures were determined using the combination of experiments shown below, which was the main finding of this study. All UV-vis-NIR spectra were recorded using an [(L)FeII(X)n]m+ concentration of 0.5 mM in MeCN, and 3 eq. PhINTs, measurements were carried out under Ar at rt.

In Fig. 2a the time-dependent spectra of the oxidation process of [(L2)FeII(MeCN)]2+ to the corresponding tosylimido complex and the subsequent decay process are shown. The close-up depicts the isosbestic point associated with the decay process, indicating that the resulting iron(III) species originates from the transformation of the iron(IV)–tosylimido species. The time traces at 780 nm for the tosylimido band and at 530 nm for the decay species are shown in Fig. 2b to illustrate the temporal progression of the decay. In Fig. 2c, the oxidation to the tosylimido species and subsequent decay are illustrated for the complex with L3, where the changes in the spectrum are relatively minor due to the charge transfer band of the tosylimido complex. Here, a shift of the charge transfer band from 475 nm to 500 nm is observed.

When [(L1)FeII(Cl)2] or [(L1)FeII(MeCN)2](OTf)2 are reacted with 3 equivalents of PhINTs, no transitions typical for high-valent iron(IV) species are observed. Instead, an intense charge transfer band around 500 nm or 480 nm is observed, depending on whether OTf or Cl are used as counter ion (see SI Fig. S1 and S2 for time-dependent UV-vis-NIR spectra). An overview of the resulting iron(III) bands for all bispidine-iron complexes is shown in Fig. 2d. It is noteworthy that the iron(III) bands of the degradation products of the assumed [(L1)FeIV[double bond, length as m-dash]NTs]2+ species, independent of the coligand, and of [(L2)FeIV[double bond, length as m-dash]NTs]2+ remain stable for several hours or days, while the iron(III) band of the degradation product of [(L3)FeIV[double bond, length as m-dash]NTs]2+ further decays within approximately 2 hours.

Mass spectrometry

Various studies have shown that high-valent iron–tosylimido species often undergo decay via protonation of the tosylimido moiety and subsequent reduction of the iron(IV) center to iron(III), resulting in the formation of an [FeIII–NHTs] species.34,47–49 Such species have, for example, been characterized in systems supported by the ligands L4 and L5. Additionally, it is known that intramolecular group attack can occur in bispidine-based systems as well as in other non-heme model complexes, leading to the degradation of the reactive species involving N-centered demethylation.41,42,50 To further investigate the degradation products of the three bispidine-based iron(IV)–tosylimido complexes, we analyzed them by high-resolution electrospray ionization mass spectrometry (HR ESI-MS) and tandem MS. An overview of the key species found in the collected spectrometric data for all complexes is provided in Table 1 (see SI Fig. S9–S20 for a complete set of spectra and Table S1 for a detailed list of all species identified).
Table 1 Most prominent decay species identified via HR ESI-MS after different aging times. Sample solutions (0.5 mM in MeCN) were stirred for a given time interval at rt after addition of 1–2 eq. PhINTs. Subsequently, the solutions were diluted to concentrations of 10−5 M and then measured
Complex Species Sum formula Mass m/z 1 min 30 mi 1 h 5 h 24 h
Int [%] Int [%] Int [%] Int [%] Int [%]
a The HR ESI-MS shows species A, B and E with charges of 1+ and 2+. The observation of the one-electron reduced or oxidized species is not unusual for transition metal complexes with reactive nitrogen ligands such as tosylamide, since these tend to undergo facile reduction or oxidation. Redox processes induced by HR ESI-MS is indicated by an asterisk (*).40,42,51,53
[(L1)FeII(MeCN)2] (OTf)2 [(L1–H)FeIII–NTs]+ (A*)a C30H32FeN5O7S+ 662.1366 16.2 100 100
[(L1–CH3)FeIII–NTs]+ (B*) C29H30FeN5O7S+ 648.1215 5.7 0.6 0.5
[(L1–H)FeIII–NTs]2+ + OH (A) C30H33FeN5O8S+ 679.1394 100 75 87.5
[(L1)FeIICl2] [(L1–H)FeIII–NTs]+ (A*) C30H33FeN5O8S+ 662.1366 30.9 100 100
[(L1–H)FeIII–NTs]2+ + Cl (A) C30H32ClFeN5O7S+ 697.1055 100 28.1 86.9
[(L2)FeII(MeCN)] (OTf)2 [(L2–H)FeIII–NTs]2+ + MeO (A) C36H38FeN6O8S+ 770.1816 100 100
[(L2–CH3)FeIII]2+ + OTf (B) C28H26F3FeN5O8S+ 705.0798 22 14
[(L2–CH2)FeIII]2+ + OTf (B) C28H27F3FeN5O8S+ 706.0876 27
[(L3)FeII(MeCN)] (OTf)2 [(L3)FeIII–NTs]+ (E) C35H36FeN6O7S+ 740.1710 79.1 100
[(L3)FeIII–NTs]2+ + OTf (E*) C36H36FeF3N6O10S2+ 889.1230 3.2 8.8 12.0 5.1


First the spectra of the oxidized tetradentate iron complexes with different counter ions were examined with HR ESI-MS. Both complexes show similar signals to those of the corresponding iron(IV)–oxido complexes.41,42 In the HR ESI-MS spectra, the dominant signal corresponds to a species reduced by one proton and one electron, formally a hydrogen atom (Scheme 2, species A). This species remains the main component for up to 24 hours. To confirm the proposed degradation pathway for the tosylimido complex, tandem-MS experiments were performed on the [(L1–H)FeIII–NTs]+ ion (Fig. 3, see SI Fig. S8 for different acceleration voltages). The spectra shows elimination of a CH2NTs fragment, consistent with demethylation of the ligand. This cleavage is mechanistically analogous to the loss of formaldehyde observed in the degradation of the corresponding oxido species (see Scheme 2), suggesting a shared degradation route for the iron(IV)–oxido and –tosylimido complexes supported by L1. UV-vis-NIR spectroscopy also supports the formation of [(L1–H)FeIII–NTs]2+ (A). For the OTf complex, an absorption band at 500 nm is observed (480 nm for Cl), which remains stable over time. Species A can further degrade via CH2NTs elimination to give species B (Scheme 2), although only trace amounts of B are detected by HR ESI-MS. The consistency between the dominant MS species and the persistent UV-vis-NIR signal supports the assignment of species A as the primary degradation product.


image file: d5dt02063h-s2.tif
Scheme 2 Postulated decay pathways of the iron(IV)–tosylimido species with bispidine ligands L1 and L2, Y is either a counter ion, solvent molecule or the pendant pyridine from the ligand. R–H is a sacrificial solvent molecule, which mediates the decay pathway.

image file: d5dt02063h-f3.tif
Fig. 3 Tandem HR ESI-MS measurement of the degradation product [(L1–H)FeIIINTs]+ (M, species A*). Isolated species (left) and fragmentation products ([M-CH2NTs]+, species B*) at 15 V acceleration voltage (right).

The complex [(L2)FeIV[double bond, length as m-dash]NTs]2+ follows the same degradation pathway as its L1 analogue. In HR ESI-MS spectra, species with cleaved methyl groups appear around 60 minutes after oxidation (see Table 1), consistent with the demethylation mechanism outlined in Scheme 2. UV-vis-NIR spectroscopy supports this assignment: an iron(III) species with an absorption band at 530 nm is observed, which decays further over time (see SI Fig. S7). Although the demethylation might proceed via an intramolecular pathway and thus be concentration-independent, the observed lifetime of [(L2)FeIV[double bond, length as m-dash]NTs]2+ varies significantly, from hours to several days, across experiments. This variability suggests that hydrogen atom transfer (HAT) involving the solvent or medium contributes to the decay mechanism (see Scheme 2). In this context, the solvent may act as a formal hydrogen donor. Analogous behavior has been reported for related iron–tosylimido complexes with tripodal urea- or amide-based ligands (L4, L5), where the [FeIV[double bond, length as m-dash]NR] species is reduced to [FeIII–NHR] via solvent-mediated HAT.34,38,52 Moreover, the presence of water accelerates this transformation, as the resulting iron(III)–amido intermediate is rapidly protonated to yield an [FeIII–OH] complex.34,38,52 Such a protonation-induced decay is consistent with the transient nature of [(L2)FeIV[double bond, length as m-dash]NTs]2+ and highlights the extreme sensitivity of [FeIV[double bond, length as m-dash]NR] species to protic impurities. Notably, the analogous oxido complex [(L2)FeIV[double bond, length as m-dash]O]2+ shows no signs of demethylation (see SI Fig. S6, S23 and S24).

No demethylation products were detected for [(L3)FeIV[double bond, length as m-dash]NTs]2+ in HR ESI-MS. Interestingly, although the corresponding oxido complex [(L3)FeIV[double bond, length as m-dash]O]2+ shows N-centred demethylation (see SI Fig. S21 and S22), the tosylimido complex yields a persistent signal at m/z 740.1710, assigned to [(L3)FeIII–NTs]+. This species reaches maximum intensity around 30 minutes after oxidation (see SI Table S1 and Fig. S9–S20). To determine whether the species observed at m/z 740.1710 represents the intact [(L3)FeIV[double bond, length as m-dash]NTs]2+ complex or a degradation product, a solution of the iron–tosylimido complex was monitored by UV-vis-NIR spectroscopy until the characteristic bands of [(L3)FeIV[double bond, length as m-dash]NTs]2+ completely vanished (see SI Fig. S3 and S17). HR ESI-MS analysis of the fully decayed solution still showed the m/z 740.1710 peak, indicating that this is not the intact iron(IV)–tosylimido complex, but a more stable decay product. Further HR ESI-MS measurements confirmed that once the charge-transfer band of this species also disappeared (SI Fig. S4 and S19), the signal at m/z 740.1710 was no longer detectable. These findings suggest that [(L3)FeIII–NHTs]2+ is the main degradation product of [(L3)FeIV[double bond, length as m-dash]NTs]2+. Under HR ESI-MS conditions, the [(L3)FeIII–NHTs]2+ species (D, Scheme 3) likely deprotonates at the NHTs group, yielding the corresponding singly charged [(L3)FeIII–NTs]+ ion E.54 Similar degradation pathways have been reported for related complexes with ligands L4 and L5.34 The formation of this decay product could also explain the varying formation rates. As proposed for the L1- and L2-based complexes, where substrate-mediated hydrogen atom transfer plays a role in tosylimido reduction, the degradation rate of [(L3)FeIV[double bond, length as m-dash]NTs]2+ likewise appears to depend on the availability of H-donors. To probe this, 10 mM (20 eq.) of 1,3-cyclohexadiene, a reagent with a relatively low HAT barrier, was added to a solution of [(L3)FeIV[double bond, length as m-dash]NTs]2+. Upon addition, the charge-transfer band immediately shifted from 475 nm to 530 nm, consistent with a rapid conversion into the [(L3)FeIII–NHTs]2+ species (see SI Fig. S5). Interestingly, despite the presence of excess 1,3-cyclohexadiene, no second HAT was observed that would yield an NH2Ts group and an iron(II) species, suggesting high stability of [(L3)FeIII–NHTs]2+. The initially formed 1,3-cyclohexadienyl radical can either recombine, undergo disproportionation to form benzene and cyclohexene, or react with another equivalent of [(L3)FeIV[double bond, length as m-dash]NTs]2+, ultimately leading to its conversion into benzene.48,55,56 The degradation pathways of [(L3)FeIV[double bond, length as m-dash]NTs]2+ are summarized in Scheme 3. In this scheme, 1,3-cyclohexadiene mediates HAT to generate the [FeIII–NHTs]2+ species (species D), which subsequently loses a proton under HR ESI-MS conditions to form the observed species E (m/z 740.1710). Alternatively, cleavage of the NHTs ligand (species F) yields iron(III) or iron(II) species, both of which are also detected by HR ESI-MS and UV-vis-NIR spectroscopy.


image file: d5dt02063h-s3.tif
Scheme 3 Decay pathways for the complex [L3FeIV[double bond, length as m-dash]NTs]2+ with 1,3-cyclohexadiene as sacrificial substrate. As proposed before, water or solvent molecules can also act as sacrificial substrate when no additional 1,3-cyclohexadiene is added.34,47

The isomeric pentadentate bispidine ligands L2 and L3 display complementary reactivity patterns in their corresponding iron(IV)–oxido and –tosylimido complexes with respect to N-centered demethylation. While [(L3)FeIV[double bond, length as m-dash]O]2+ undergoes demethylation, the analogous [(L3)FeIV[double bond, length as m-dash]NTs]2+ complex stops at hydrogen atom transfer from a sacrificial substrate, yielding a protonated tosylamide. Conversely, [(L2)FeIV[double bond, length as m-dash]O]2+ remains inert toward demethylation, whereas [(L2)FeIV[double bond, length as m-dash]NTs]2+ induces formal C–N bond cleavage. These contrasting behaviors arise from a combination of complex geometry and intrinsic oxidant properties. The oxido ligand in [(L2)FeIV[double bond, length as m-dash]O]2+ is well stabilized by the ligand field and remains unreactive toward the adjacent N–CH3 group.57 In the tosylimido analogue [(L2)FeIV[double bond, length as m-dash]NTs]2+, however, the bulkier and electronically distinct NTs group experiences greater steric strain, which not only enhances its general reactivity, as seen in tosylimido atom transfer reactions,40 but also facilitates intramolecular demethylation via HAT and subsequent C–N bond cleavage. In the case of L3-based complexes, the situation is reversed. The FeIV[double bond, length as m-dash]O moiety in [(L3)FeIV[double bond, length as m-dash]O]2+ is sufficiently basic and accessible to abstract a hydrogen atom from the ligand's N–CH3 group, thereby initiating demethylation. The corresponding tosylimido complex [(L3)FeIV[double bond, length as m-dash]NTs]2+, though capable of HAT, does not proceed beyond formation of a protonated tosylamide. Previous density functional theory calculations (DFT) show that, for the two pentadentate tosylimido species, equatorial coordination of the NTs group leads to a larger Fe–N–S angle than axial coordination (150° vs. 140°).40 This more linear arrangement decreases the σ overlap of Fe dx2y2 and enhances the π overlap of dxz/dxy with N p orbitals, thereby increasing the multiple-bond character of the Fe[double bond, length as m-dash]NTs unit.18 The stronger π bond with the NTs group decreases the stability of the lone pair at the nitrogen and thus increases the reactivity towards ligand self-decay. In contrast, the more bent arrangement (≈140°) in the axial case leads to a weaker orbital overlap resulting in reduced π interaction, making self-decay less favorable. Accordingly, in [(L2)FeIV[double bond, length as m-dash]NTs]2+ geometric and electronic factors appear to stabilize the transient α-amino radical formed after HAT and thus enable C–N bond cleavage, whereas in [(L3)FeIV[double bond, length as m-dash]NTs]2+ the same intermediate is kinetically trapped, either due to a less favorable in-plane approach geometry or an insufficient driving force for bond scission, so that no complete degradation occurs. To further support the hypothesis of different decay pathways, EPR and Mössbauer spectra were recorded to further characterize the various species.

Mössbauer and EPR spectroscopy

After identifying [(L3)FeIII–NHTs]2+ (species DScheme 3) and [(L1/2−H)FeIII–NTs]2+ (species AScheme 2) as the primary decay product of their respective tosylimido-complexes, the resulting iron(III) complexes were further characterized by EPR and Mössbauer spectroscopy. The Mössbauer samples were prepared by allowing the solutions of oxidized iron complex to age for 10–90 minutes, followed by rapid freezing in Teflon cups placed on a nitrogen-cooled metal block. At this point, corresponding to the MS data, the [(L1/2−H)FeIII–NTs]2+ and [(L3)FeIII–NHTs]2+ species are expected to be dominant species. First, the spectra of [(L1/2−H)FeIII–NTs]2+ are examined. The Mössbauer spectra of both [(L1–H)FeIII–NTs]2+ and [(L2−H)FeIII–NTs]2+ exhibit signatures consistent with high-spin ferric centers (see Fig. 4a–c). For comparison, Mössbauer parameters and EPR data for the most important species are summarized in Table 2. All three complexes display identical isomer shifts of δ = 0.48 mm s−1, differing only in their quadrupole splittings: ΔEQ = 1.19, 0.83 and 0.59 mm s−1, for [(L1–H)FeIII–NTs(Cl)](Cl), [(L1–H)FeIII–NTs(MeCN)](OTf)2 and [(L2−H)FeIII–NTs](OTf)2, respectively. The uniform isomer shifts and minor ΔEQ differences corroborate the common degradation mechanism. In addition to the expected high-spin iron(III) species associated with [(L1/2−H)FeIII–NTs]2+ (species A in Scheme 2),41,42 an additional high-spin iron(III) signal appears in the Mössbauer spectra of the decayed [(L1)FeIV[double bond, length as m-dash]NTs(MeCN)](OTf)2, which is absent in the others.
image file: d5dt02063h-f4.tif
Fig. 4 (a) Mössbauer (left) and EPR measurements (right) of the degradation species of the complex [(L1)FeIV[double bond, length as m-dash]NTs(Cl)](Cl) Mössbauer measurement: δ = 0.48, ΔEQ = 1.19 mm s−1; [FeII] 1.0 mM, 2–3 eq. PhINTs, MeCN, 80 K, aged for 10 min at rt before measurement; EPR measurement: f = 9.631378 GHz; aged for 5 h at rt, [FeII] 2 mM, 2–3 eq. PhINTs, MeCN, 10 K. (b) Mössbauer (left) and EPR measurements (right) of the degradation species of the complex [(L1)FeIV[double bond, length as m-dash]NTs(MeCN)](OTf)2. Mössbauer measurement: black solid line: iron(III) species (1) δ = 0.48, ΔEQ = 0.83 mm s−1; black dashed line: iron(III) species (2) δ = 0.55, ΔEQ = 1.74 mm s−1; gray dotted line: iron(II) complex δ = 1.10, ΔEQ = 3.18 mm s−1; gray solid line: simulated measurement curve. [FeII] 1.0 mM, 2–3 eq. PhINTs, MeCN, 80 K, aged for 10 min at rt before measurement. EPR measurement: f = 9.633 158 GHz (right). [FeII] 2 mM, 2–3 eq. PhINTs, MeCN, 5–10 K, aged for 5 h at rt before measurement. (c) Mössbauer (left) and EPR measurements (right) of the degradation species of the complex [(L2)FeIV[double bond, length as m-dash]NTs](OTf)2. Mössbauer measurement: black solid line: high-spin iron(III) species δ = 0.48, ΔEQ = 0.59 mm s−1; black dashed line: iron(IV) species δ = −0.01, ΔEQ = 0.69 mm s−1; gray line: simulated measurement curve. Aged for 90 min at rt, [FeII] 1.0 mM, 2–3 eq. PhINTs, MeCN, 80 K. EPR measurement: Aged for 24 h at rt, f = 9.632 442 GHz, [FeII] 2 mM, 2–3 eq. PhINTs, MeCN, 5–10 K. (d) Mössbauer (left) and EPR measurements (right) of the degradation species of the complex [(L3)FeIV[double bond, length as m-dash]NTs](OTf)2. Mössbauer measurement: black solid line: low-spin iron(III) species δ = 0.32, ΔEQ = 2.28 mm s−1; black dashed line: high-spin iron(III) species δ = 0.35, ΔEQ = 1.06 mm s−1; gray line: simulated measurement curve. Aged for 15 min at rt [FeII] 1.0 mM, 2–3 eq. PhINTs, MeCN, 80 K. EPR measurement: aged for 40 min at rt, f = 9.634 350 GHz, [FeII] 2 mM, 2–3 eq. PhINTs, MeCN, 5–10 K.
Table 2 Spectroscopic characterization of degradation products derived from bispidine-based iron(IV)–tosylimido complexes and related systems bearing the ligands L4 and L5 depicted in Fig. 1
Complex S λ [nm] (ε [mol−1 cm−1]) δ [mm s−1] ΔEQ [mm s−1] g (xy; z)
[(L1–H)FeIII–NTs(Cl)]Cl (species A) 5/2 480 0.48 1.19 4.21
[(L1)FeII(MeCN)2](OTf)2 2 410 (1558) 1.10 3.18
[(L1–H)FeIII–NTs(MeCN)](OTf)2 (species A) 5/2 500 0.48 0.83 4.30
[(L1–H)FeIII–NTs(MeCN)](OTf)2 (species A) 1/2 2.18; 1.49
[(L1)FeIII(MeCN)2](OTf)2 (species B) 5/2 0.55 1.74
[(L2)FeIV[double bond, length as m-dash]NTs](OTf)2 1 735 −0.01 0.69
[(L2−H)FeIII–NTs](OTf)2 (species A) 5/2 530 (2500) 0.48 0.59 4.33
[(L2−H)FeIII–NTs](OTf)2 (species A) 1/2 2.24; 1.91
[(L3)FeIII–NHTs](OTf)2 (species D) 1/2 500 0.32 2.28 2.27; 1.91
[(L3)FeIII(MeCN)](OTf)2 (species F) 5/2 0.35 1.06 4.28
[(L4)FeIII–NHTs](OTf)2[thin space (1/6-em)]34 1/2 468 0.27 −2.03 2.24; 1.95
[(L5)FeIII–NHTs](OTf)2[thin space (1/6-em)]34 1/2 472 0.28 2.40 2.23; 1.93


To gain further insight, EPR spectra were recorded (Fig. 4a–c). Samples of the L1-based complexes were measured 5 h and of L2-based complexes 24 h after oxidation to ensure strong signals of [(L1/2−H)FeIII–NTs]2+. In addition to the expected high-spin signal, a low-spin iron(III) species was also detected for the triflate complexes (L1 and L2), with particularly strong intensity for the L1 derivative. These low-spin features are absent in the corresponding chloride complex and are not reflected in the Mössbauer spectra, likely due to the higher measurement temperature (80 K vs. 8–12 K in EPR), which favors the high-spin state. The observation aligns with known temperature-dependent spin equilibria in bispidine-based iron(III) complexes.58 The tendency of the triflate derivatives to form low-spin species is attributed to MeCN coordination, which is favored in the absence of strongly coordinating anions like chloride.

Based on the MS, EPR, and Mössbauer data, it is assumed that the additional high-spin iron(III) signal observed in the Mössbauer spectrum of [(L1–H)FeIII–NTs(MeCN)](OTf)2 arises from ligand exchange of the –CH2NTs group. This group appears to be labile and readily replaceable, a process that is suppressed in the corresponding chloride complex due to coordination of the chloride anion, and in the pentadentate ligand complex due to the altered ligand field. Supporting this interpretation, UV-vis-NIR data also show a slower decay of the degradation product when chloride is present (see SI Fig. S1 and S2), consistent with a reduced rate of –CH2NTs dissociation. Ligand exchange may be triggered, for instance, during the freezing step of the Mössbauer sample preparation, as this was performed outside the glovebox. Under such conditions, moisture may condense into the sample during cooling and lead to exchange to an aqua or hydroxido ligand. This assignment is consistent with previous DFT calculations on analogous oxido complexes, which showed that Fe–CH2O bonds are relatively weak and prone to dissociation,41 as well as previous studies who reported a fast ligand exchange with traces of water.52 It is therefore plausible that the Fe–CH2NTs bond in the current system is similarly labile.

For the complex derived from L3, the data point to a distinct degradation pathway involving formation of an [(L3)FeIII–NHTs]2+ species. This is reflected in the Mössbauer spectrum (Fig. 4d), which, unlike the spectra of the L1- and L2-derived complexes, is dominated by a low-spin iron(III) species with an isomer shift of δ = 0.32 mm s−1 and a quadrupole splitting of ΔEQ = 2.28 mm s−1. These parameters are consistent with previously reported [(L4/5)Fe–NHTs]+ complexes, which are also low-spin (see Table 2).34 A minor high-spin component is detectable, both in the Mössbauer and in the corresponding EPR spectra (Fig. 4d), indicating the presence of a second, structurally distinct iron(III) species. Notably, an additional EPR spectrum recorded five hours after oxidation (see SI Fig. S25) reveals only the high-spin signal, suggesting a time-dependent interconversion. At this point, the UV-vis-NIR spectrum shows no remaining charge-transfer band (see SI Fig. S4), indicating complete loss of the tosylimido-derived functionality. This late-stage species is therefore assigned, by analogy to the triflate L1 complex, to an iron(III) center lacking any –NTs or –NHTs ligand, likely formed via displacement in the course of degradation (species F, Scheme 3). Taken together, the data support the formation of a transient [(L3)FeIII–NHTs]2+ species as the dominant early-stage degradation product for [(L3)FeIV[double bond, length as m-dash]NTs]2+, followed by slower conversion to a high-spin iron(III) species devoid of the original tosylimido moiety.

Group transfer to styrene

The investigation of the degradation pathways and products of the oxidized bispidine-iron complexes indicates that an active iron(IV)-tosylimido species also has to be present for the complexes with L1. To further support this assumption, the NTs group transfer capability of the complexes was examined. For this purpose, the tosylimido group transfer onto styrene was studied for the tetradentate bispidine iron complex. In a catalytic reaction, PhINTs was combined with the substrate styrene, followed by the addition of a 5 mM iron(II) solution in MeCN (cat[thin space (1/6-em)]:[thin space (1/6-em)]ox[thin space (1/6-em)]:[thin space (1/6-em)]sub = 1[thin space (1/6-em)]:[thin space (1/6-em)]20[thin space (1/6-em)]:[thin space (1/6-em)]100, rt, Ar). Upon completion of the reaction, indicated by formation of a clear solution (the limited solubility of the oxidant in MeCN leads to turbidity), both the yield and the approximate duration, and thus a qualitative measure of the reaction rate, were determined. The results are summarized in Table 3. Product formation was observed for all complexes studied, supporting the formation of a reactive tosylimido species for all bispidine-iron complexes. However, differences in yields and TOFs were noted. Both the yield and TOF were significantly higher for the complex with the tetradentate ligand and chloride counter ion, compared to the triflate analogue. [(L1)FeIV[double bond, length as m-dash]NTs(Cl)](Cl) exhibits more than double the yield and a substantially shorter reaction time. The same trend is observed as in the analogous oxido system: the coordination of a halide accelerates the reaction compared to a coordinated acetonitrile molecule, and this was shown to be due to ligand field dependent spin-state energetics. For tetradentate bispidine-iron(IV)–oxido complexes the triplet-quintet gap is markedly smaller with chloride than with a weakly coordinating ligand, enabling more facile two-state reactivity and faster productive group transfer, and we therefore expect an analogous coligand dependent spin-gap effect for the bispidine-based FeIV[double bond, length as m-dash]NTs species as well.59 Comparing these results with those with the pentadentate ligand systems, it is evident that the yield for [(L2)FeIV[double bond, length as m-dash]NTs]2+ is higher than that for [(L3)FeIV[double bond, length as m-dash]NTs]2+, but the TOF is lower. The system with L3 exhibits by far the highest TOF among the bispidine systems investigated here.
Table 3 Yields and TOFs of the catalytic experiments with styrene using bispidine iron complexes. ([FeII] 5 mM, 20 eq. PhINTs, 100 eq. styrene (cat[thin space (1/6-em)]:[thin space (1/6-em)]ox[thin space (1/6-em)]:[thin space (1/6-em)]substrate 0.05[thin space (1/6-em)]:[thin space (1/6-em)]1[thin space (1/6-em)]:[thin space (1/6-em)]5), MeCN, Ar, rt)
Complex Yield [% Ox] Duration TOF [h−1] Lit.
[(L1)FeIICl2] 39.0 (1.4) 64 min 18.5 (0.3) This work
[(L1)FeII(MeCN)2]OTf2 16.5 (3.3) 21 h 45 min 0.9 (0.5) This work
[(L2)FeII(MeCN)]OTf2 33.5 (1.5) 3 h 13 min 6.3 (3.1) 40
[(L3)FeII(MeCN)]OTf2 20.0 (1.2) 36 min 32.9 (2.3) 40


Conclusion

This work reveals distinct degradation mechanisms for bispidine–iron(IV)–tosylimido complexes and demonstrates how subtle changes in ligand topology and coordination geometry critically influence the reactivity and stability of these systems. While the tetradentate ligand L1 and the pentadentate ligand L2 direct the system toward a shared cyclic degradation pathway involving high-spin [(L1/2−H)FeIII–NTs]2+ species leading to N-centered demethylation, the L3 based complex follows an orthogonal route via formation of a low-spin [(L3)FeIII–NHTs]2+ species. This mechanistic divergence highlights the role of axial vs. equatorial tosylimido coordination in governing the fate of reactive intermediates. The indirect identification of the reactive [(L1)FeIV[double bond, length as m-dash]NTs]2+ species via its degradation products, together with successful NTs group transfer to styrene across all systems studied, provides both mechanistic insight and functional evidence for the tosylimido reactivity of iron complexes. The tosylimido complexes bearing tetradentate ligands display a higher reactivity in comparison to other tosylimido species, consistent with the behavior of their oxido analogues, that they cannot be detected spectroscopically under standard conditions.

Experimental section

Methods and materials

All chemicals and reagents were purchased from commercial sources (ABCR; ACROS, Sigma-Aldrich; TCI). Dry acetonitrile was purified using an MB SPS 5 solvent purification system from MBraun. Air-sensitive materials were prepared and handled using either Schlenk techniques or in a glovebox under Ar atmosphere. The oxidant (N-(p-toluenesulfonyl)imino)phenyliodinane (PhINTs) was synthesized according to the procedures of Yamada et al. and Evans et al., washed with dichloromethane, and stored in a glovebox at −30 °C under argon until its use.60–62 All Data were analyzed and visualized using OriginPro 2020, unless otherwise stated.

HR ESI-MS experiments were carried out on an ApexQe hybrid 9.4 T FT-ICR from Bruker. Tandem mass experiments were carried out on a timsTOFfleX mass spectrometer from Bruker. For MS and tandem MS measurements samples with iron complex concentrations of 10−5 M were prepared. For the investigation of the oxidized iron species, the reactions were carried out under the same conditions as used for the other measurements (in dry MeCN in a glove box under argon), and were diluted accordingly for the MS measurements (details see SI). The measurements were carried out by the Mass Spectrometry Facility, Department of Chemistry, University of Heidelberg, Heidelberg, Germany.

Elemental analyses were performed on a CHN-O Vario EL by the “Mikroanalytisches Labor”, Department of Chemistry, Heidelberg University, Heidelberg, Germany.

UV-vis-NIR spectra were recorded on an Agilent 8453 spectrophotometer equipped with an USP-203-A cryostat from Unisoku.

57 Fe Mössbauer spectra were recorded on an alternating constant-acceleration spectrometer using iron-57 enriched samples. The minimal line-width was 0.24 mm s−1 full-width at half-height. The sample temperature was maintained constant in a bath cryostat (Wissel MBBC-HE0106). 57Co/Rh was used as the radiation source. Isomer shifts were determined relative to α-iron at room temperature.

EPR spectra were recorded on a Bruker ELEXSYS-E500 instrument. The measurements were made in vertical mode at X-band (microwave frequency 9.63461–9.63691 GHz) The spectrometer was equipped with a F-70 Sumitomo cryogenics helium cryostat, Bruker ER4116-DM resonator, Oxford LLT 650 low loss transfer tube, and an Oxford ITC503 temperature controller. EPR tubes (3 mm, quartz) were filled with 200 μL of sample.

NMR spectra were recorded at 400 MHz (1H) and 101 MHz (13C) on Avance II or at 600 MHz (1H) and 151 MHz (13C) on Avance III instruments from Bruker with the solvent as internal reference.

Product analysis of bulk oxidation reactions. Standard conditions for the reaction with iron(IV)–tosylimido species: In a glove box, a 1.5 ml glass vial was equipped with a stirring bar, 1 eq. of PhINTs (15–20 mg) and 5 eq. of substrate (ca. 30 μl styrene). The reaction was started by addition of a 5 mM solution of the FeII complex (0.1 eq.), dissolved in dry, absolute MeCN. The sequence of substrate addition was chosen to avoid potential side reactions and to ensure that as soon as the tosylimido species is formed, it can react with the substrate. The reaction was stopped after 17 h. For the work-up, the vials were taken out of the glovebox and the solutions were filtered over a silica pipette column to separate the iron catalysts. The columns were washed with 3 ml EtOAc and the combined filtrate was evaporated at 40 °C. The aziridination yields were determined by 1H NMR spectroscopy. Therefore, 1,3,5-trimethoxybenzene (5 to 15 mg – exact amount noted) was added as internal standard to the residue, which was dissolved CD2Cl2. All experiments were performed twice. Yields are with respect to used amount of oxidant.

Preparation of the ligands and complexes

The ligands and iron(II) complexes used were synthesized according to literature known procedures and characterization by NMR, HR ESI-MS and elemental analyses.63–65
[(L1)FeII(MeCN)2]OTf2 . EA (C27H29FeF6N5O11S2) [%]: calc.: C, 38.91; H, 3.51; N, 8.40; exp.: C, 38.70; H, 3.70; N, 8.40. HR ESI-MS (pos., MeCN): m/z = 643.0765 (100%) (calc.: 643.0767) [FeII(L1) + OTf]+.
[(L1)FeIICl2] . EA (C25H29Cl2FeN5O5·H2O) [%]: calc.: C, 48.10; H, 5.01; N, 11.22, exp.: C, 47.98; H, 5.02; N, 10.94. HR ESI-MS (pos., MeCN):m/z = 529.0938 (100%) (calc.: 529.0936) [FeII(L1) + Cl]+.
[(L2)FeII(MeCN)]OTf2 . EA (C32H32FeF6N6O11S2·2H2O) [%]: calc.: C, 40.60; H, 3.83; N, 8.88; exp.: C, 40.80; H, 3.89; N, 8.59. HR ESI-MS (pos., MeCN): m/z = 720.1030 (100%) (calc.: 720.1033) [FeII(L2) + OTf]+.
[(L3)FeII(MeCN)]OTf2 . EA (C32H32FeF6N6O11S2·2H2O) [%]: calc.: C, 40.60; H, 3.83; N, 8.88; exp.: C, 40.65; H, 3.74; N, 8.31. HR ESI-MS (pos., MeCN): m/z = 606.1190 (99%) (calc.: 606.1201) [FeII(L3) + Cl]+, m/z = 624.1295 (100%) (calc.: 624.1307) [FeII(L3) + Cl + H2O]+.
[(L1) 57FeII(MeCN)2]OTf2 . EA (C25H28FeF6N4O12S2·0.5 MeCN) [%]: calc.: C, 37.53; H, 3.57; N, 7.58, exp.: C, 37.37; H, 3.58; N, 7.69. HR ESI-MS (pos., MeCN/MeOH): m/z = 526.1436 (61%) (calc.: 526.1435) [57FeII(L1) + OMe]+, m/z = 644.0772 (100%) (calc.: 644.0773) [57FeII(L1) + OTf]+.
[(L1) 57FeIICl2] . EA (C23H28Cl2FeN4O6·0.75 MeCN) [%]: calc.: C, 47.84; H, 4.96; N, 10.82, exp.: C, 47.90; H, 4.89; N, 10.75. HR ESI-MS (pos., MeCN/MeOH): m/z = 530.0941 (61%) (calc.: 530.0940) [57FeII(L1) + Cl]+, m/z = 562.1203 (100%) (calc.: 562.1202) [57FeII(L1) + Cl + MeOH]+.
[(L2) 57FeII(MeCN)]OTf2 . EA (C32H32FeF6N6O11S2·MeOH·0.5H2O) [%]: calc.: C, 41.60; H, 3.91; N, 8.82; exp.: C, 41.67; H, 3.97; N, 8.74. HR ESI-MS (pos., MeCN): m/z = 721.1038 (100%) (calc.: 721.1037) [FeII(L2) + OTf]+.
[(L3) 57FeII(MeCN)]OTf2 . EA (C30H31FeF6N5O12S2·0.25MeCN·0.5H2O) [%]: calc.: C, 40.35; H, 3.64; N, 8.10; exp.: C, 40.38; H, 3.72; N, 8.06. HR ESI-MS (pos., MeCN): m/z = 607.1207 (100%) (calc.: 607.1206) [FeII(L3) + Cl]+.

Author contributions

The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript. K. B. prepared the original draft and performed MS and EPR measurements and experiments regarding the iron(IV)–oxido complexes. T. J. contributed to data visualization, writing through review and editing, and carried out major parts of the investigation, including UV-vis-NIR, MS, and EPR measurements as well as sample preparation for Mössbauer spectroscopy. F. R. performed the Mössbauer measurements. T. G. provided resources and contributed to writing through review and editing. P. C. provided resources, supervision, and contributed to writing through review and editing.

Conflicts of interest

There are no conflicts to declare.

Data availability

Supplementary information (SI): protocols for sample preparation, MS data, aziridination experiments, EPR spectra, and UV/Vis-NIR spectra. See DOI: https://doi.org/10.1039/d5dt02063h.

Raw data are stored on the university servers and can be accessed via the corresponding author if necessary.

Acknowledgements

Financial support by the German Science Foundation (DFG) within the Research Unit FOR 5215 “Bioinspired Oxidation Catalysis with Iron Complexes (“BioOxCat”) to P. C. (TP4) and T. G. (TP1) is gratefully acknowledged.

References

  1. G. Coin and J. M. Latour, J. Inorg. Biochem., 2021, 225, 111613 CrossRef CAS PubMed.
  2. K. Ray, F. F. Pfaff, B. Wang and W. Nam, J. Am. Chem. Soc., 2014, 136, 13942–13958 CrossRef CAS PubMed.
  3. X. Engelmann, I. Monte-Pérez and K. Ray, Angew. Chem., Int. Ed., 2016, 55, 7632–7649 CrossRef CAS PubMed.
  4. M. N. Cosio and D. C. Powers, Nat. Rev. Chem., 2023, 7, 424–438 CrossRef CAS PubMed.
  5. M. Guo, T. Corona, K. Ray and W. Nam, ACS Cent. Sci., 2019, 5, 13–28 CrossRef CAS PubMed.
  6. J. Hohenberger, K. Ray and K. Meyer, Nat. Commun., 2012, 3, 720 CrossRef PubMed.
  7. C. Krebs, D. G. Fujimori, C. T. Walsh and J. M. Bollinger Jr., Acc. Chem. Res., 2007, 484–492 CrossRef CAS PubMed.
  8. M. M. Abu-Omar, A. Loaiza and N. Hontzeas, Chem. Rev., 2005, 105, 2227–2252 CrossRef CAS PubMed.
  9. A. R. McDonald and L. Que, Coord. Chem. Rev., 2013, 257, 414–428 CrossRef CAS.
  10. W. Nam, Acc. Chem. Res., 2015, 48, 2415–2423 CrossRef CAS PubMed.
  11. E. I. Solomon, K. M. Light, L. V. Liu, M. Srnec and S. D. Wong, Acc. Chem. Res., 2013, 46, 2725–2739 CrossRef CAS PubMed.
  12. W. Nam, Y. M. Lee and S. Fukuzumi, Acc. Chem. Res., 2014, 47, 1146–1154 CrossRef CAS PubMed.
  13. F. Avenier and J. M. Latour, Chem. Commun., 2004, 4, 1544–1545 RSC.
  14. M. P. Jensen, M. P. Mehn and L. Que, Angew. Chem., Int. Ed., 2003, 42, 4357–4360 CrossRef CAS PubMed.
  15. C. A. Grapperhaus, B. Mienert, E. Bill, T. Weyhermu and K. Wieghardt, Inorg. Chem., 2000, 39, 5306–5317 CrossRef CAS PubMed.
  16. X. Li, L. Dong and Y. Liu, Inorg. Chem., 2020, 59, 1622–1632 CrossRef CAS PubMed.
  17. N. W. Goldberg, A. M. Knight, R. K. Zhang and F. H. Arnold, J. Am. Chem. Soc., 2019, 141, 19585–19588 CrossRef CAS PubMed.
  18. S. Hong, K. D. Sutherlin, A. K. Vardhaman, J. J. Yan, S. Park, Y. M. Lee, S. Jang, X. Lu, T. Ohta, T. Ogura, E. I. Solomon and W. Nam, J. Am. Chem. Soc., 2017, 139, 8800–8803 CrossRef CAS PubMed.
  19. P. Müller and C. Fruit, Chem. Rev., 2003, 103, 2905–2919 CrossRef PubMed.
  20. P. F. Kuijpers, J. I. van der Vlugt, S. Schneider and B. de Bruin, Chem. – Eur. J., 2017, 23, 13819–13829 CrossRef CAS PubMed.
  21. G. Dequirez, V. Pons and P. Dauban, Angew. Chem., Int. Ed., 2012, 51, 7384–7395 CrossRef CAS PubMed.
  22. E. Vitaku, D. T. Smith and J. T. Njardarson, J. Med. Chem., 2014, 57, 10257–10274 CrossRef CAS PubMed.
  23. S. D. Roughley and A. M. Jordan, J. Med. Chem., 2011, 54, 3451–3479 CrossRef CAS PubMed.
  24. J. Castro, X. Westworth, R. Shrestha, K. Yokoyama and Z. Guan, Adv. Mater., 2024, 36, 1–7 CrossRef PubMed.
  25. F. Thomas, M. Oster, F. Schön, K. C. Göbgen, B. Amarouch, D. Steden and A. Hoffmann, Dalton Trans., 2021, 50, 6444–6462 RSC.
  26. Y. Ren, J. Forté, K. Cheaib, N. Vanthuyne, L. Fensterbank, H. Vezin, M. Orio, S. Blanchard and M. Desage-El Murr, iScience, 2020, 23(3), 100955 CrossRef CAS PubMed.
  27. K. Bleher, P. Comba, M. Gast, S. Kronenberger and T. Josephy, Inorg. Chim. Acta, 2022, 532, 120752 CrossRef CAS.
  28. P. Comba, M. Merz and H. Pritzkow, Eur. J. Inorg. Chem., 2003, 1711–1718 CrossRef CAS.
  29. P. Comba, C. Lang, C. L. De Laorden, A. Muruganantham, G. Rajaraman, H. Wadepohl and M. Zajaczkowski, Chem. – Eur. J., 2008, 14, 5313–5328 CrossRef CAS PubMed.
  30. J. A. Halfen, J. M. Uhan, D. C. Fox, M. P. Mehn and L. Que, Inorg. Chem., 2000, 39, 4913–4920 CrossRef CAS PubMed.
  31. T. Josephy, M. Heiduk, T. Saxl and K. Bleher, Inorg. Chim. Acta, 2025, 122587 CrossRef CAS.
  32. V. Bagchi, A. Kalra, P. Das, P. Paraskevopoulou, S. Gorla, L. Ai, Q. Wang, S. Mohapatra, A. Choudhury, Z. Sun, T. R. Cundari and P. Stavropoulos, ACS Catal., 2018, 8, 9183–9206 CrossRef CAS PubMed.
  33. H. Nishikori, C. Ohta, E. Oberlin, R. Irie and T. Katsuki, Tetrahedron, 1999, 55, 13937–13946 CrossRef CAS.
  34. G. Sabenya, I. Gamba, L. Gómez, M. Clémancey, J. R. Frisch, E. J. Klinker, G. Blondin, S. Torelli, L. Que, V. Martin-Diaconescu, J. M. Latour, J. Lloret-Fillol and M. Costas, Chem. Sci., 2019, 10, 9513–9529 RSC.
  35. E. J. Klinker, T. A. Jackson, M. P. Jensen, A. Stubna, G. Juhász, E. L. Bominaar, E. Münck and L. Que, Angew. Chem., Int. Ed., 2006, 45, 7394–7397 CrossRef CAS PubMed.
  36. S. Kumar, A. S. Faponle, P. Barman, A. K. Vardhaman, C. V. Sastri, D. Kumar and S. P. De Visser, J. Am. Chem. Soc., 2014, 136, 17102–17115 CrossRef CAS PubMed.
  37. A. K. Vardhaman, P. Barman, S. Kumar, C. V. Sastri, D. Kumar and S. P. De Visser, Angew. Chem., Int. Ed., 2013, 52, 12288–12292 CrossRef CAS PubMed.
  38. G. Mukherjee, F. G. C. Reinhard, U. K. Bagha, C. V. Sastri and S. P. de Visser, Dalton Trans., 2020, 49, 5921–5931 RSC.
  39. K. Bleher, P. Cieslik and P. Comba, Dalton Trans., 2025, 54, 4405 RSC.
  40. T. Josephy, R. Kumar, K. Bleher, F. Röhs, T. Glaser, G. Rajaraman and P. Comba, Inorg. Chem., 2024, 63, 12109–12119 CrossRef CAS PubMed.
  41. M. Abu-Odeh, K. Bleher, N. J. Britto, P. Comba, M. Gast, M. Jaccob, M. Kerscher, S. Krieg and M. Kurth, Chem. – Eur. J., 2021, 27, 11377–11390 CrossRef CAS PubMed.
  42. J. England, Y. Guo, E. R. Farquhar, V. G. Young, E. Münck and L. Que, J. Am. Chem. Soc., 2010, 132, 8635–8644 CrossRef CAS PubMed.
  43. A. Nielsen, F. B. Larsen, A. D. Bond and C. J. McKenzie, Angew. Chem., Int. Ed., 2006, 45, 1602–1606 CrossRef CAS PubMed.
  44. X. Lu, X. X. Li, Y. M. Lee, Y. Jang, M. S. Seo, S. Hong, K. Bin Cho, S. Fukuzumi and W. Nam, J. Am. Chem. Soc., 2020, 142, 3891–3904 CrossRef CAS PubMed.
  45. Y. Liu, X. Guan, E. L. M. Wong, P. Liu, J. S. Huang and C. M. Che, J. Am. Chem. Soc., 2013, 135, 7194–7204 CrossRef CAS PubMed.
  46. A. Decker, J. U. Rohde, L. Que and E. I. Solomon, J. Am. Chem. Soc., 2004, 126, 5378–5379 CrossRef CAS PubMed.
  47. E. Gouré, D. Senthilnathan, G. Coin, F. Albrieux, F. Avenier, P. Dubourdeaux, C. Lebrun, P. Maldivi and J. M. Latour, Angew. Chem., Int. Ed., 2017, 56, 4305–4309 CrossRef PubMed.
  48. X. X. Li, X. Lu, J. W. Park, K. Bin Cho and W. Nam, Chem. – Eur. J., 2021, 27, 17495–17503 CrossRef CAS PubMed.
  49. X. Lu, X. X. Li, M. S. Seo, Y. M. Lee, M. Clémancey, P. Maldivi, J. M. Latour, R. Sarangi, S. Fukuzumi and W. Nam, J. Am. Chem. Soc., 2019, 141, 80–83 CrossRef CAS PubMed.
  50. P. Comba, B. Pokrandt and H. Wadepohl, Aust. J. Chem., 2017, 70, 576–580 CrossRef CAS.
  51. K. Bleher, P. Comba, J. H. Gross and T. Josephy, Dalton Trans., 2022, 51, 8625–8639 RSC.
  52. R. L. Lucas, D. R. Powell and A. S. Borovik, J. Am. Chem. Soc., 2005, 127, 11596–11597 CrossRef CAS PubMed.
  53. J. H. Gross, Mass Spectrometry, Springer Nature, 3rd edn, 2017 Search PubMed.
  54. C. J. Conder, H. Jawale and P. G. Wenthold, Mass Spectrom. Rev., 2023, 42, 1604–1624 CrossRef CAS PubMed.
  55. M. H. Studier and E. J. Hart, J. Am. Chem. Soc., 1969, 91, 4068–4072 CrossRef CAS.
  56. B. D. Michael and E. J. Hart, J. Phys. Chem., 1970, 74, 2878–2884 CrossRef CAS.
  57. P. Comba, S. Fukuzumi, C. Koke, B. Martin, A. M. Löhr and J. Straub, Angew. Chem., Int. Ed., 2016, 55, 11129–11133 CrossRef CAS PubMed.
  58. J. Bautz, P. Comba and L. Que Jr., Inorg. Chem., 2006, 45(18), 7077–7082 CrossRef CAS PubMed.
  59. P. Comba, G. Nunn, F. Scherz and P. H. Walton, Faraday Discuss., 2021, 234, 232–244 RSC.
  60. D. A. Evans, M. M. Faul and M. T. Bilodeau, J. Org. Chem., 1991, 56, 6744–6746 CrossRef CAS.
  61. D. A. Evans, M. M. Paul and M. T. Bilodeau, J. Am. Chem. Soc., 1994, 116, 2742–2753 CrossRef CAS.
  62. Y. Yamada, T. Yamamoto and M. Okawara, Chem. Lett., 1975, 361–362 CrossRef CAS.
  63. H. Börzel, P. Comba, K. S. Hagen, Y. D. Lampeka, A. Lienke, G. Linti, M. Merz, H. Pritzkow and L. V. Tsymbal, Inorg. Chim. Acta, 2002, 337, 407–419 CrossRef.
  64. C. Mannich and P. Mohs, Ber. Dtsch. Chem. Ges., 1930, 63, 608–612 CrossRef.
  65. P. Comba, M. Kerscher and W. Schiek, Prog. Inorg. Chem., 2007, 55, 613–704 CAS.

Footnote

For the time trace the absorption at 780 nm was chosen, although the absorption maximum is at 730 nm, as no absorption of the charge transfer band is observed at 780 nm and thus the progression of the dd absorption can be more clearly represented.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.